We teach doctors all over the world

Press

Elravie Re2O's Key Opinion Leader

Dr. Woong Choi, Head Doctor, is a Key Opinion Leader for Elravie Re2O, recognized for his extensive clinical experience and consistent treatment outcomes.


In recognition of his expertise, Dr. Choi received a Certificate of Appreciation from Humedix, the manufacturer of Elravie Re2O. This distinction was awarded to only 20 medical institutions nationwide in Korea, highlighting his proven clinical excellence.


Dr. Choi continues to deliver safe, precise, and refined Re2O treatments, supported by deep expertise and ongoing clinical research.

2026-01-12
Seminar

Treatment Training at VS Line Clinic

Medical professionals from Oman and Indonesia visited VS Clinic Signature Center to learn from the diverse procedural experience and clinical expertise accumulated in Korea.


Through this visit, we shared education based on real clinical cases and refined treatment techniques, creating a meaningful opportunity for international medical exchange.

2025-12-24
Press

AMWC (Aesthetic & Anti-Aging Medicine World Congress) Japan

VS Line Clinic is pleased to announce that Dr. Choi, Head Doctor at VS Line Clinic Apgujeong Signature Center, was invited as a speaker at AMWC Japan 2025, one of the world’s leading congresses in aesthetic and anti-aging medicine.

During the seminar, Dr. Choi delivered a specialized lecture on advanced Juvelook techniques, sharing in-depth clinical insights, treatment protocols, and real-case outcomes with an international audience of aesthetic physicians and industry professionals. His presentation highlighted the evolving role of regenerative aesthetics in skin rejuvenation, reinforcing Korea’s position as a global leader in the field.

Participation in AMWC Japan reflects our ongoing commitment to advancing evidence-based aesthetic medicine and contributing to global medical education. VS Line Clinic will continue to promote the value of Korean aesthetic expertise through research, innovation, and international collaboration.

2025-11-18
Press

L’Oréal Team visit to VS Line Clinic

We were honored to welcome the CEO of L’Oréal from France, along with the L’Oréal team, to VS Line Clinic Apgujeong Signature Center. Together with Dr. Choi, we engaged in meaningful discussions about the future of Korean aesthetic medicine and the evolving standards of beauty. It was a valuable exchange of insights, innovation, and vision — bringing together global expertise and Korean excellence. We look forward to continuing this collaboration as we work toward a more advanced and inclusive future in aesthetics.

2025-11-03
Seminar

ASLS 2025 Leaders Forum

Dr. Choi was once again recognized for his leadership in the field as he presented his study, The Regeneration Triangle, at the 2025 Leaders Forum of the Aesthetic Surgery and Laser Society (ASLS). The presentation explored innovative approaches to tissue regeneration and aesthetic harmony, emphasizing evidence-based techniques that enhance both safety and results.

2025-10-25
Seminar

Dr. Choi – Humedix Webinar Speaker

Dr. Choi was also invited as a key speaker for the Humedix Webinar, where he discussed the latest developments in collagen treatments and answered live questions from practitioners worldwide. His talk focused on the clinical applications, long-term results, and future directions of next-generation collagen stimulators.

2025-09-24
Seminar

Juvelook I&G Launching Symposium 2025

At the Juvelook New Product Launch Symposium 2025, Dr. Choi presented his research and clinical study on the new Juvelook G. His session provided an in-depth look into the product’s development background, real-world treatment outcomes, and responses from clinical trials. The symposium served as an important milestone for Juvelook’s next chapter—with Dr. Choi contributing valuable expertise at the forefront of discussion.

2025-09-13
Seminar

International Clinic Visits

Our clinic frequently welcomes visitors from overseas who come to learn about our systems, protocols, and patient-centered approach. In recent months, we have hosted doctors and clinic directors from China, Taiwan, Saudi Arabia, Singapore, Vietnam, and Indonesia—each seeking to observe our operations and apply similar models to their own practices. These visits highlight our clinic’s position as a trusted reference point in the region.

2025-09-13
Seminar

Dr. Jung – International Aesthetic Industry Conference (Chengdu)

Dr. Jung was invited as a speaker at the International Aesthetic Industry Conference in Chengdu, China, where she presented insights into the growing influence of K-beauty in the global aesthetic market. Her presentation explored innovation trends, patient preferences, and the evolution of Korean treatment technology that continues to shape the international aesthetic landscape.

2025-09-06
Seminar

Dr. Choi – RE20 Collagen Treatment Demonstration

Dr. Choi recently conducted a live demonstration on the RE20 Collagen Treatment, showcasing advanced treatment protocols and detailed product usage. During the session, he guided fellow doctors through the scientific background, technique optimization, and expected clinical outcomes—helping practitioners better understand the potential of collagen-based rejuvenation.

2025-07-18

Privacy Policy

브이에스라인클리닉(hereinafter referred to as the "Company") has established the following privacy policy to protect users' personal information and rights in accordance with the Personal Information Protection Act when using the website (vslineclinic.web-factory.co.kr) and related services, and to handle users' grievances smoothly.

1. Consent to the Collection of Personal Information

The Company provides a procedure for users to agree to the collection and use of personal information when applying for individual services. Users can refuse consent, but refusal may restrict the use of the relevant services.

2. Purpose of Collection and Use of Personal Information

The purposes for which the Company collects and uses users' personal information are as follows

Category Purpose of Use
Inquiry Verification of intention according to online inquiry, identity verification, prevention of fraudulent use of services, various notifications and guidance, and record preservation for dispute resolution

3. Personal Information Collection Items and Methods

The Company collects only the essential information required to provide basic services. Optional information can be left blank without limiting the use of the service. The Company does not use the collected information for purposes other than those stated.

Category Collection and Use Items
Inquiry (Required) Inquiry type, name, contact information, email, contact information, inquiry details

The Company collects personal information through the completion of application forms on the website by users.

4. Retention and Use Period of Personal Information

The Company processes and retains users' personal information for one year from the date of consent to the collection and use of personal information. However, if it is necessary to retain personal information for a certain period according to the provisions of related laws, the information will be retained for that period, and access to and use of the retained information will be restricted for the relevant reasons.

5. Entrustment or Provision of Personal Information to Third Parties

  1. The Company does not provide users' personal information to third parties, including other individuals, companies, or institutions. The Company does not entrust users' personal information.
  2. If it becomes necessary to entrust personal information for service improvement in the future, users will be notified in advance, and the Company will manage the entrusted party through an outsourcing contract.

6. Procedures and Methods for Destroying Personal Information

  1. In principle, if the purpose of processing personal information is achieved, and the personal information processing is deemed unnecessary, or if the user requests the destruction of personal information, the Company will promptly destroy the relevant personal information. The procedures, deadlines, and methods for destruction are as follows:
  2. Information subject to destruction is transferred to a separate database (DB) or document file after the purpose is achieved and is destroyed without delay according to internal policies and other relevant laws. Personal information transferred to a separate DB or document file is not used for any other purpose except as required by law.
  3. Personal information is destroyed within 5 days from the end of the retention period or within 5 days from when it is recognized that the information is no longer necessary due to the achievement of the processing purpose, discontinuation of the relevant service, or termination of the business.
  4. Information stored in electronic file format is deleted using technical methods that prevent record reproduction, and information printed on paper is shredded with a shredder.

7. 7. Rights and Obligations of Information Subjects and Legal Representatives and How to Exercise Them

  1. Information subjects can exercise the following rights against the Company at any time:
    • Right to request access to personal information
    • Right to request correction or deletion of personal information
    • Right to request the suspension of processing personal information
    • Right to withdraw consent to the collection, use, etc., of personal information
  2. Information subjects can request access, correction, deletion, suspension of processing, withdrawal of consent, or destruction of personal information from the personal information protection officer listed below, and the Company will take necessary measures without delay.
  3. The rights under items 1 and 2 must be exercised by the information subject themselves. If the information subject’s legal representative or an entrusted person wishes to exercise these rights, the Company may request additional documents such as a power of attorney.
  4. Information subjects must not use or infringe upon their or others' personal information in violation of personal information protection laws and must manage their information under their responsibility.

8. Methods of Notification or Notice of Privacy Policy

If the Company uses personal information beyond the scope of the user's consent or provides it to a third party, it will obtain the user's additional consent individually. If the Company entrusts the processing of personal information to another party, it will notify this in advance through the privacy policy on the website.

9. Technical and Managerial Measures for Personal Information Protection

  1. Establishment and implementation of an internal management plan: The Company has established and is implementing an internal management plan for the safe processing of personal information.
  2. Technical measures against hacking, etc.: The Company installs security programs, performs periodic updates and checks to prevent personal information leakage and damage caused by hacking or computer viruses.
  3. Training of personal information processing staff: Personal information processing staff are composed of the minimum number of people, and the Company provides regular training and prepares internal procedures regarding personal information protection obligations.

10. 10. Personal Information Protection Officer

The Company appoints a personal information protection officer to protect users' personal information and handle complaints.

Name
Position Personal Information Protection Officer
Phone
E-mail

11. 11. Changes to the Privacy Policy

This privacy policy was established on September 23, 2022.
This privacy policy will be applied from the effective date. In case of any additions, deletions, or corrections to the content according to laws and policies, the changes will be notified to users 7 days before the effective date, and in case of significant changes that are disadvantageous to users, they will be notified 30 days before the effective date.